Answers are grounded in this paper and cite their sources.
Observational analysis shows high morbidity and mortality from tumor-associated hemorrhages in pediatric low-grade glioma, indicating the need for molecular risk assessments.
Background/Purpose: Tumor-associated hemorrhages are rare complications in pediatric low-grade glioma (pLGG). While pLGG generally presents excellent survival rates, intracranial bleedings correlate with high morbidity and mortality. Recent studies discuss potential molecular risk factors such as FGFR and PTPN11 mutations in the tumor. With the rise of targeted therapies that influence the underlying tumor-driving molecular patterns, the need to understand the relationship between this rare complication and molecular features grows. The German national registry HIT-LOGGIC for pLGG offers a platform of consultation to 60 pediatric oncology centers.
No takes yet. Share an insight, caveat, or question.
Großer et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: